Jacinta A. Holmes

1.7k total citations
51 papers, 947 citations indexed

About

Jacinta A. Holmes is a scholar working on Epidemiology, Hepatology and Rheumatology. According to data from OpenAlex, Jacinta A. Holmes has authored 51 papers receiving a total of 947 indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Epidemiology, 37 papers in Hepatology and 6 papers in Rheumatology. Recurrent topics in Jacinta A. Holmes's work include Hepatitis C virus research (34 papers), Hepatitis B Virus Studies (28 papers) and Liver Disease Diagnosis and Treatment (25 papers). Jacinta A. Holmes is often cited by papers focused on Hepatitis C virus research (34 papers), Hepatitis B Virus Studies (28 papers) and Liver Disease Diagnosis and Treatment (25 papers). Jacinta A. Holmes collaborates with scholars based in Australia, United States and China. Jacinta A. Holmes's co-authors include Alexander Thompson, Raymond T. Chung, Paul Desmond, Ming‐Lung Yu, A. Thompson, Shadi Salloum, Nadia Alatrakchi, Annie J. Kruger, Sally Bell and David Iser and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Hepatology.

In The Last Decade

Jacinta A. Holmes

50 papers receiving 925 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jacinta A. Holmes Australia 20 629 612 125 105 97 51 947
Arnolfo Petruzziello Italy 14 873 1.4× 816 1.3× 162 1.3× 106 1.0× 55 0.6× 24 1.2k
Valeria Piazzolla Italy 16 861 1.4× 910 1.5× 70 0.6× 121 1.2× 58 0.6× 43 1.1k
Bach‐Nga Pham France 16 394 0.6× 461 0.8× 95 0.8× 104 1.0× 41 0.4× 44 1.0k
Carmela Cacciapuoti Italy 11 663 1.1× 628 1.0× 93 0.7× 84 0.8× 41 0.4× 20 925
Xiaoguang Dou China 16 377 0.6× 388 0.6× 112 0.9× 56 0.5× 65 0.7× 72 638
Sara Cmet Italy 15 559 0.9× 666 1.1× 95 0.8× 91 0.9× 54 0.6× 35 1.0k
Laure Elkrief France 18 1.1k 1.8× 1.2k 1.9× 142 1.1× 77 0.7× 396 4.1× 45 1.5k
Fredric Regenstein United States 16 1.1k 1.7× 1.0k 1.6× 73 0.6× 117 1.1× 130 1.3× 33 1.3k
Ming‐Yen Hsieh Taiwan 23 1.8k 2.9× 1.8k 3.0× 130 1.0× 116 1.1× 134 1.4× 112 2.2k
Shinn‐Cherng Chen Taiwan 25 1.9k 2.9× 1.8k 2.9× 95 0.8× 123 1.2× 132 1.4× 117 2.2k

Countries citing papers authored by Jacinta A. Holmes

Since Specialization
Citations

This map shows the geographic impact of Jacinta A. Holmes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacinta A. Holmes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacinta A. Holmes more than expected).

Fields of papers citing papers by Jacinta A. Holmes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacinta A. Holmes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacinta A. Holmes. The network helps show where Jacinta A. Holmes may publish in the future.

Co-authorship network of co-authors of Jacinta A. Holmes

This figure shows the co-authorship network connecting the top 25 collaborators of Jacinta A. Holmes. A scholar is included among the top collaborators of Jacinta A. Holmes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacinta A. Holmes. Jacinta A. Holmes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Griffin, S., Shelley Walker, Jacinta A. Holmes, et al.. (2025). "Quick, simple, and friendly": Understanding the acceptability and accessibility of a nurse and peer-led, mobile model of hepatitis C care adjacent to community corrections in Australia. International Journal of Drug Policy. 139. 104785–104785. 1 indexed citations
2.
Fareh, Mohamed, Wenxin Hu, Vitina Sozzi, et al.. (2024). CRISPR-Cas13b-mediated suppression of HBV replication and protein expression. Journal of Hepatology. 81(5). 794–805. 8 indexed citations
3.
Cogger, Shelley, Matthew J. Penn, Anthony M. Weeks, et al.. (2024). Point-of-care HCV RNA testing improves hepatitis C testing rates and allows rapid treatment initiation among people who inject drugs attending a medically supervised injecting facility. International Journal of Drug Policy. 125. 104317–104317. 2 indexed citations
4.
Cogger, Shelley, Matthew J. Penn, Anthony M. Weeks, et al.. (2023). Eliminating hepatitis C in Australia: a novel model of hepatitis C testing and treatment for people who inject drugs at a medically supervised injecting facility. The Medical Journal of Australia. 218(6). 256–261. 3 indexed citations
5.
Altınbaş, Akif, Jacinta A. Holmes, Shadi Salloum, et al.. (2022). LOXL-2 and TNC-C Are Markers of Liver Fibrogenesis in HCV/HIV-, HIV- and HCV-Infected Patients. Biomarkers in Medicine. 16(11). 839–846. 2 indexed citations
6.
Fehily, Sasha R., et al.. (2022). Isolated esophageal IgG4-related disease presenting with progressive dysphagia and weight loss in a middle-aged man. Clinical Journal of Gastroenterology. 15(3). 526–530. 1 indexed citations
7.
Wright, Emily K., Jacinta A. Holmes, Alexander Thompson, et al.. (2021). Telehealth model of care for outpatient inflammatory bowel disease care in the setting of the COVID‐19 pandemic. Internal Medicine Journal. 51(7). 1038–1042. 20 indexed citations
9.
Salloum, Shadi, Annie J. Kruger, Jacinta A. Holmes, et al.. (2021). Fatty Acids Activate the Transcriptional Coactivator YAP1 to Promote Liver Fibrosis via p38 Mitogen-Activated Protein Kinase. Cellular and Molecular Gastroenterology and Hepatology. 12(4). 1297–1310. 37 indexed citations
10.
Holmes, Jacinta A., et al.. (2020). Hepatitis C Virus Infection in Pregnancy. Gastroenterology Nursing. 43(1). 12–21. 13 indexed citations
11.
Holmes, Jacinta A. & Raymond T. Chung. (2020). New approaches in viraemic organ transplantation and antiviral therapies. Nature Reviews Gastroenterology & Hepatology. 17(2). 78–79. 3 indexed citations
12.
Yeh, Ming‐Lun, Chung‐Feng Huang, Ching‐I Huang, et al.. (2020). Hepatitis B-related outcomes following direct-acting antiviral therapy in Taiwanese patients with chronic HBV/HCV co-infection. Journal of Hepatology. 73(1). 62–71. 43 indexed citations
13.
Nguyen, Tin, David Iser, Jacinta A. Holmes, et al.. (2017). Efficacy and safety of tenofovir in chronic hepatitis B: Australian real world experience. World Journal of Hepatology. 9(1). 48–48. 19 indexed citations
14.
Holmes, Jacinta A. & Raymond T. Chung. (2016). HCV compartmentalization in HCC: driver, passenger or both?. Nature Reviews Gastroenterology & Hepatology. 13(5). 254–256. 5 indexed citations
15.
Sise, Meghan E., Jessica Wisocky, Ivy A. Rosales, et al.. (2016). Lupus-Like Immune Complex-Mediated Glomerulonephritis in Patients With Hepatitis C Virus Infection Treated With Oral, Interferon-Free, Direct-Acting Antiviral Therapy. Kidney International Reports. 1(3). 135–143. 23 indexed citations
16.
Holmes, Jacinta A. & Alexander Thompson. (2015). Interferon-free combination therapies for the treatment of hepatitis C: current insights. PubMed. 7. 51–51. 41 indexed citations
17.
Thompson, A. & Jacinta A. Holmes. (2015). Treating hepatitis C – what’s new?. Australian Prescriber. 38(6). 191–197. 4 indexed citations
18.
Holmes, Jacinta A., Stuart K. Roberts, Gregory J. Dore, et al.. (2014). ITPA genotype protects against anemia during peginterferon and ribavirin therapy but does not influence virological response. Hepatology. 59(6). 2152–2160. 22 indexed citations
19.
Holmes, Jacinta A., Alexander Thompson, & Sally Bell. (2013). Hepatitis C--an update.. PubMed. 42(7). 452–6. 10 indexed citations
20.
Holmes, Jacinta A., Paul Desmond, & Alexander Thompson. (2011). Redefining Baseline Demographics: The Role of Genetic Testing in Hepatitis C Virus Infection. Clinics in Liver Disease. 15(3). 497–513. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026